Neuroscientific Biopharmaceuticals Ltd. (AU:NSB) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Neuroscientific Biopharmaceuticals Ltd. has announced the cessation of 1,175,000 options due to expiry without exercise or conversion on April 6, 2024. This financial update, relevant for investors tracking the company’s capital structure, reflects changes in the securities issued by the firm.
For further insights into AU:NSB stock, check out TipRanks’ Stock Analysis page.